UNH logo

UnitedHealth Group

UNH · What the business does, what can go wrong, and how options sellers approach it

What it does

UnitedHealth Group is a large U.S. health care company with two main arms. UnitedHealthcare is a health insurer that sells plans to employers, individuals, and government program participants, including Medicare Advantage and Medicaid plans. Optum is a collection of health services businesses covering pharmacy benefits, outpatient and physician care, data and analytics, and financial services for the health system.

How it makes money

The insurance side collects monthly premiums and pays out medical claims. Its profit is roughly what is left after claims and administrative costs, so pricing and cost control matter a great deal.

Optum earns fees and service revenue. It manages prescription drug benefits, runs care delivery, and sells technology and analytics to health plans, providers, and employers, including UnitedHealthcare itself.

Why investors own it

  • Scale: a very large member base helps spread costs and gives it leverage in negotiating with providers.
  • Diversification: insurance and services businesses can balance each other across different parts of the health system.
  • Steady demand: health care spending tends to hold up in weak economies.
  • Capital returns: the company has historically paid a dividend. Dividends are never guaranteed.
  • Index membership: it is a component of the S&P 500 and the Dow Jones Industrial Average.

What can go wrong

  • Medical costs can rise faster than premiums, squeezing margins.
  • Government programs are a big part of the business, so changes in payment rates or rules can matter a lot.
  • Regulators and lawmakers scrutinize its size, pharmacy benefit practices, and ties between insurance and care delivery.
  • Its scale makes antitrust and legal risk a recurring theme.
  • Cyberattacks or operational failures can disrupt services and bring costs and reputational harm.

What to watch

  • Medical care ratio (share of premiums spent on claims)
  • Medical cost trends and utilization
  • Medicare Advantage rate announcements and policy changes
  • Membership growth by plan type
  • Optum revenue and operating margin
  • Regulatory and legal developments
  • Management guidance versus results

Options income angle

Options on UNH are typically liquid, with many strikes and expirations, and heavy trading in the nearest few expirations. Implied volatility tends to rise ahead of quarterly earnings and around government payment-rate decisions, policy news, or legal and regulatory headlines.

One caution for premium sellers: this stock can gap sharply on a single news event or earnings report. A short put or covered call position can face a large move that overwhelms the premium collected, so position size and assignment risk deserve careful thought.

What the latest 10-K says

A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed March 2, 2026. Figures are as the filing reports them. Read the filing on SEC.gov

The filing in brief

UnitedHealth Group grew revenue in 2025, but profit fell sharply because medical costs ran well above what the company priced for. Earnings from operations were $19.0 billion compared to $32.3 billion the year before. The filing points to Medicare Advantage funding, rising care use and costly Optum Health value-based contracts as the main pressures going into 2026.

How the business did

  • Total revenues were $447,567 million, up 12%, driven by Medicare Advantage growth, higher-need Medicaid members, growth at Optum Rx and pricing. Diluted earnings per share were $13.23 compared to $15.51.
  • The medical care ratio (medical costs divided by premium revenue, so higher is worse) rose to 89.1% from 85.5%. Management says 2025 pricing assumptions fell "well-short" of the medical cost trends actually incurred.
  • Optum Health swung to an operating loss of $278 million from earnings of $7,770 million. Optum Rx earnings rose to $7,193 million from $5,836 million.
  • Fourth-quarter restructuring and other actions had a total impact of $2.5 billion. They included a $623 million loss contract reserve for expected 2026 losses in certain value-based care businesses and a $799 million increase in reserves for provider loans tied to the Change Healthcare cyberattack.
  • Cash provided by operating activities was $19,697 million. The company paid $7,916 million in dividends and repurchased $5,545 million of common shares.

Risks specific to this company

  • Government program funding: Medicare Advantage, Medicare Part D and Medicaid bring in substantial revenue. CMS has cut or frozen payment benchmarks before, and additional cuts are possible.
  • Audits and star ratings: Plans need four stars or higher to earn quality bonuses. CMS risk adjustment data validation audits can lead to retroactive payment adjustments and fines.
  • Cost estimation: Premium revenues from risk-based products are nearly 80% of total revenues. Small gaps between predicted and actual medical costs can swing results, and cost overruns generally cannot be recovered within the fixed premium period.
  • Goodwill and credit ratings: Goodwill and other intangibles carry a value of $131 billion, 42% of total consolidated assets, so an impairment charge would be large. Moody's, S&P Global and Fitch each list a negative outlook on senior unsecured debt.
  • Cyberattack aftermath: The 2024 Change Healthcare attack involved protected health information. The company also notes acquired businesses can carry weaker systems and different litigation exposure.
  • Pharmacy benefit scrutiny: Government agencies are investigating pharmacy benefit manager practices, which could result in civil penalties or hurt the business model of Optum Rx.

What management is watching

  • Shrinking enrollment in 2026: Management expects Medicare Advantage membership to contract, along with people served under value-based care. It also expects Medicaid losses from reduced eligibility and an exit from one state.
  • Medicare Advantage rates: The Advanced Notice for 2027 is described as "far below" expected medical cost trend. The company can respond by adjusting benefits, networks and premiums, and by choosing counties annually.
  • Medical costs: Management points to higher care activity, unit costs and service intensity. It says these trends may continue.
  • Value-based care shift: Moving from fee-for-service to fully accountable value-based care is described as a key focus of future growth, but it requires upfront system and clinical costs.
  • Capital and measures: The annual dividend rate is $8.84 per share, and the Board has authorized repurchases of up to 21 million shares. The company points investors to people served and adjusted scripts as main drivers of revenue and earnings. It also notes that Optum Financial moves into Optum Insight from January 1, 2026.

What the latest 10-Q says

A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed November 3, 2026. Figures are as the filing reports them. Read the filing on SEC.gov

The quarter in brief

UnitedHealth Group's profit rose sharply in the third quarter even though revenue was roughly flat. Earnings from operations were $6,563 million, compared with $4,315 million a year earlier, on total revenues of $112,694 million versus $113,161 million. The company served 1.8 million fewer people in UnitedHealthcare, while a lower medical care ratio (the share of premium revenue spent on medical costs) helped earnings.

How the business did

  • Revenue: Third-quarter total revenues were $112,694 million, and nine-month revenues were $336,447 million versus $334,352 million. The quarterly dip came from fewer people in Medicare Advantage, commercial risk-based plans, Medicaid and Optum Health value-based arrangements, partly offset by pricing.
  • Profit: Diluted earnings per share were $4.56 versus $2.59, and $17.50 versus $13.21 for nine months. The medical care ratio was 88.4% versus 89.9%. The company credits favorable prior period reserve development (earlier claim estimates that proved too high), cost management, pricing and benefit changes, partly offset by elevated medical cost trend, including higher provider payments under the No Surprises Act.
  • Segments: Optum Health earnings from operations were $735 million versus $41 million, on revenue of $22,910 million versus $25,422 million. UnitedHealthcare earnings were $2,831 million versus $1,805 million. Optum Rx fulfilled 393 million adjusted scripts versus 414 million.
  • Unusual items: Net portfolio divestitures produced gains of $224 million for the quarter and $415 million for nine months. Nine-month results also include a $400 million contribution to the United Health Foundation.
  • Cash and capital return: Nine-month operating cash flow was $25,087 million versus $18,589 million. The company paid $6,170 million in dividends and spent $5,031 million on share repurchases. In June 2026 the annual dividend rate rose to $9.28 from $8.84 per share.

What management is watching

  • Medicare Advantage funding: Management says the Final Notice for 2027 moved toward expected industry medical cost trend but remains below it, and that revisions to the risk adjustment model will continue to reduce funding. Its 2026 and 2027 benefit design already reflects this, and it can adjust benefits, networks, premiums and counties served.
  • Medicaid and commercial costs: Management describes a timing mismatch between rising care activity and state rate updates, with continued downward pressure on Medicaid margin percentages. Commercial cost trend is elevated, and the company has pledged to rebate 2026 profits on its individual exchange products.
  • Spending and measures: The company continues to invest in process and technology. It points investors to people served, adjusted scripts, the medical care ratio and the operating cost ratio. Moody's, S&P Global and Fitch all list negative outlooks on its senior debt.

Follow UNH in Kortex

The Kortex app shows UNH's price, options chain and IV rank, and answers your questions from live market data and SEC filings.

Free to download.

Learn the strategies

More stock briefs

For education only, not financial advice. Options involve risk and are not suitable for every investor.